<code id='71B84BF777'></code><style id='71B84BF777'></style>
    • <acronym id='71B84BF777'></acronym>
      <center id='71B84BF777'><center id='71B84BF777'><tfoot id='71B84BF777'></tfoot></center><abbr id='71B84BF777'><dir id='71B84BF777'><tfoot id='71B84BF777'></tfoot><noframes id='71B84BF777'>

    • <optgroup id='71B84BF777'><strike id='71B84BF777'><sup id='71B84BF777'></sup></strike><code id='71B84BF777'></code></optgroup>
        1. <b id='71B84BF777'><label id='71B84BF777'><select id='71B84BF777'><dt id='71B84BF777'><span id='71B84BF777'></span></dt></select></label></b><u id='71B84BF777'></u>
          <i id='71B84BF777'><strike id='71B84BF777'><tt id='71B84BF777'><pre id='71B84BF777'></pre></tt></strike></i>

          leisure time

          leisure time

          author:Wikipedia    Page View:75267
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more
          CDC Director Mandy Cohen on transparency, trust, and health
          CDC Director Mandy Cohen on transparency, trust, and health

          CDCDirectorMandyCohenCliffOwen/APThenewdirectoroftheCentersforDiseaseControlandPrevention,MandyCohen

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

          DarronCummings/APScientistsattheFoodandDrugAdministrationhavetwobigquestionsaboutEliLilly’sexperimen